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From the 
-11 President 
The world hates change, 
yet it is the only thing that 
has brought progress. 
Charles F. Kettering 
There are those who would suggest 
that the only thing that changes faster 
than the Spring weather in New 
England is the medical climate in 
America today. It's been some time 
now since we, as a medical staff, have 
enjoyed the "Golden Era" of medicine 
if we ever did. We are immersed in a 
cultural revolution of legal and 
insurance oversight, increasing 
expectations, manpower plans, and 
hospital affiliations. 
' 
Well, we_here_~!.~ehigh Valley 
Hospital..are.aboutto undergo amajor -
change. As you know, on-Wednesday, · 
August 6, 1997, the Board of Trustees 
of Lehigh Valley Hospital and 
Muhlenberg Hospital Center 
announced their intentions to merge 
the two institutions. While this 
merger will have very significant 
positive effects with regards both to 
providing better integrated health 
systems and programs to the 
Allentown and Bethlehem 
communities and to improving the 
merged institutional financial base and 
credit rating, this action is bound to 
raise serious concerns on the parts of 
members ofboth medical staffs. The 
medical staff leadership at both 
Muhlenberg Hospital Center and 
Lehigh Valley Hospital realize that 
there are some very significant issues 
facing us in this new Lehigh Valley 
Hospital Health Network. These 
concerns have caused us to defer any 
immediate merging of the two medical 
staffs. Instead, we plan to take on 
these issues prior to any attempt at 
merging staffs. I ask that members of 
the Lehigh Valley Hospital medical 
staff communicate your concerns and 
hopes to a member of the Medical 
Executive Committee, Troika, or 
myself so we can continue to repres, , .. t 
you responsibly at the negotiation 
table. 
It also appears that the nature of 
PennCARE will be changing slightly 
An a way in which the .effect it will 
have on the medical staff at Lehigh 
Valley Hospital is unclear. Abington 
Hospital has applied for membership 
in PennCARE and the PennCARE 
Board has accepted their application. 
Obviously, this means that Lehigh 
Valley Hospital will no longer be the 
only medical community able to 
provide tertiary care to PennCARE 
(Continued on Page 2) 
.. 
(Continued from Page 1) 
subscribers. This will necessitate that 
our staff be able to be better at 
"COOPITITION'' than our Abington 
colleagues. While we must cooperate 
to insure the integrity of the Integrated 
Delivery System which helps protect 
us from the competition in 
Philadelphia, atAllegheny, at 
Columbia/HCA and others, we must 
be able to be better at providing the 
absolute finest care in a financially 
responsible manner so as to insure that 
the obvious choice for medical care 
will most certainly be the physicians 
on this medical staff. 
So too, as in any climate of change, 
some prefer to change climates. I 
would be remiss if I did not publicly 
recognize colleagues and friends who 
will be leaving Allentown to begin 
practice elsewhere. To Larry 
Feldman, Paul Guillard, John Samies, 
and David Vargas, thank you for all 
you have done for the people of the 
Lehigh Valley during your tenure here 
and thank you for all·the help and 
support you provided to me. 
On a more uplifting note, however, WP 
as a medical staff should celebrate anL 
recognize the recent U.S. News & 
World Report which ranked the 
geriatrics and urology programs at 
Lehigh Valley Hospital as among the 
nation's finest. While, on a more local 
level, we recognize the tremendous 
talent embodied in the staff here, it is 
gratifying to see our brethren 
recognized on a national level as well. 
Congratulations to Fran Salerno and 
Ed Mullin and all the members of your 
respective divisions! 
Finally, as a reminder, our next 
General Medical Staff meeting will be 
held on Monday, September 8, at 5:30 
p.m., in the auditorium at Cedar Crest 
& I-78. I look forward to seeing all of 
you there! 
President, Medical Staff 
Robert X. Murphy, Jr., MD 
) 
At-Large Member Needed for Medical Executive Committee 
Due to the recent resignation of John 
H. Samies, MD, from the Medical 
. .Executive.:... Committee, ~e~ Medical._ 
StaffNoftll.nating-Committeeis~~··- .. 
seekiri.g.noiriinations· to"fillthe ·vacant 
seat with the term ending June 30, 
1999. The election will be held at the 
General Medical Staff meeting on 
September 8. Nominations will be 
accepted from the floor at the meeting. 
If you have any questions regarding 
this issue, please contact David M. 
Caccese, MD, Chairman of the 
Nominating Committee, or John W. 
Hart, Vice President, at 402-8980. 
-·~· ================~· 
. .... Jbere~willbe.a.meeting of the General 
Medical Staff on Monday, September 8, 
beginning at 5:30p.m., in the Auditorium at 
Cedar Crest & 1-78. All members of the 
Medical Staff are encouraged to attend. 
Immediately following the meeting, a 
reception will be held in honor of the 
Divisions of Geriatrics and Urology which 
were recently ranked among the nation's 







Semi-Annual Needs Survey 
By now, you should have received a 
memo dated August 15, 1997, which 
marks the beginning of the Semi-
Annual Needs Survey for the Medical 
Staff as called for in the Hospital Staff 
Development Plan. The purpose of 
these surveys is to reView the clinical 
specialtY needs of the Hospital. 
Under the Hospital Staff Development 
Plan, requests for slots in the Active 
and Associate categories must be 
made via the semi-annual needs 
survey. You may document any need 
for additional personpower (in your 
group, division, or other department) 
by completing the Hospital Staff 
Development Specification Statement, 
which is available in the office of 
Medical Staff Services at Cedar Crest 
& 1-78. 
Your completed request form must be 
received in the office of Medical Staff 
Services at Cedar Crest & 1-78 NO 
LATER THAN SEPTEMBER 14, 
1997 in order that it may be included 
in this semi-annual needs survey 
. which will result in the Board of 
Trustees taking action on these 
requests for slots at the January 7, 
1998 meeting. 
As part of the process, it is required 
that you discuss your request with the 
___ _::.Dep~ep.t Chairp_~<?n, obtaining hi~ 
· signature (on the Hospital :Staff 
DevelOpment Specification Statement) 
to indicate that the discussion took 
place, prior to the September 14 
deadline. Your request will later be 
reviewed by the appropriate 
Department Chairperson in 
consultation with the Division and 
Section Chiefbefore being presented 
to the Hospital Staff Development 
Advisory Committee, the Performance 
Improvement/Staff Development 
Committee of the Board of Trustees, 
and the Board of Trustees. The 
Department Chairperson will acquire 
input concerning all slot requests in a 
manner determined by each 
department and the Staff Development 
Plan. 
Please be reminded that all Active 
and Associate staff appointments, at 
Lehigh Valley Hospital, where there· 
exist no presently approved slots, will 
require processing in this manner. 
If you have any questions regarding 
this process, please contact either John 
W. Hart, Vice President, or Beth 
Martin, Executive Secretary, at 
402-8980. 
Attention Physicians and 
Office Managers 
Medical Staff dues letters will be 
distributed shortly. Timely 
remittance of dues is both 
requested and appreciated. 
·· A General Membership meeting of · 
the Greater -Lehigh Valley 
Independent Practice 
Association, Inc~, will be held on 
Tuesday, September 23, at 6 p.m., 
in the Auditorium at 
Cedar Crest & I· 78. 
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L VH Ranks Again on America's Best Hospitals List 
Lehigh Valley Hospital ranked as one 
of the top providers in the nation for 
geriatrics and urology in U.S. News & 
World Report's eighth annual guide to 
"America's Best Hospitals." 
Geriatrics was ranked for the second 
year in a row and is the only hospital 
in Pennsylvania, outside of 
Philadelphia and Pittsburgh, to be 
recognized for care of elderly people. 
This was the first year L VH's urology 
program was ranked. 
According to magazine officials, the 
top 42 medical centers in any specialty 
should be considered a leading center. 
The geriatrics program at L VH was 
introduced in 1990 by Francis A. 
Salerno, MD. The Division of 
Geriatrics provides educational 
programs, clinical services, research 
and community outreach. More than 
30 of the hospital's doctors are 
certified in geriatrics, but the program 
really involves all ofthe staff at LVH. 
Geriatrics was ranked 41. 
"I feel we still have a great deal of · 
work to do and there are a number of 
activities being planned and 
implemented,'~ Dr. Salerno said. "We 
aspire to be in the top 10 next year." 
Part of that is the Vitality Plus 
program for people 50 and older. 
Members receive benefits of health 
and education programs, hospital 
amenities, social events and discounts. 
Urology has 10 board-certified . 
physicians who run a continence 
program for women and an oncology 
program. The division is also involved 
in Prostate Awareness Week, a 
program held each September that 
offers free prostate cancer screenings. 
Currently, the Division of Urology is 
working to implement brachytherapy, 
implantation of radioactive seeds in 
the prostate to treat prostate cancer, 
and a continence program for men, 
said Edward M. Mullin, Jr., MD, 
Chief, Division ofUrology. The 
program was ranked 27. 
"We have one of the busiest urology 
services in the country, which we were 
not aware of,'' Dr. Mullin said. "While 
all the members felt we were 
practicing a high quality of urology as 
well as a high volume, the Division of 
Urology is certainly gratified by the 
official and public recognition of its 
efforts and proud of its performance. 
We have a good group of doctors that 
work hard for excellence in patient 
care." 
- "~One'ofthe most -sucoessftd geiiatrics - - ·.,. ' -
··pregra.m&46-the-~atric .. ______ --~Accor.ding..to U.S . ..News & World 
Evaluation Service (AGES). Geriatric Report, this year's "America's Best 
specialists evaluate the patient's Hospitals" lists assessed care for 17 
medical, functional, psychological, specialties at 135 hospitals 
social and economic needs and then nationwide. Rankings for 13 of the 
recommend treatment options, living specialties were based on reputation 
arrangements and community agencies and various medical data. The 
to provide assistance and family hospital was evaluated on its 
support. The goal is to help the patient reputation, mortality rate, service mi1 
remain independent as long as 







(Continued from Page 4) 
and technology. Those specialties 
included: AIDS, cancer, cardiology, 
endocrinology, gastroenterology, 
geriatrics, gynecology~ neurology, 
orthopedics, otolaryngology; 
pulmonary disease, rheumatology and 
urology. Rankings in ophthalmology, 
· pediattics, psychiatry and 
rehabilitation were based on reputation 
alone. 
To be considered for ranking, a 
hospital had to be a member of the 
Council of Teaching Hospitals 
(COTH), or be affiliated with a 
medical school, or have a score of 10 
or more on a scale of available 
hospital technology. This year, 1,800 
hospitals were evaluated. 
Colleagues: 
After 25 years of leading the clinical research mission in Allentown, Dr. David 
Prager is stepping down as Senior Investigator for the Eastern Cooperative 
Oncology Group (ECOG) and Principal Investigator for the National Surgical 
Adjuvant Breast and Bowel Project (NSABP) at Lehigh Valley Hospital. 
Widely recognized as establishing the practice of medical oncology and 
hematology in Allentown, Dr. Prager has been instrumental in guiding first the 
Allentown Hospital, and more recently, the Lehigh Valley Hospital through the 
development of their cancer program. In particular, he was the medical director 
of the cancer program when the John and Dorothy Morgan Cancer Center was 
completed in 1993. 
I will succeed Dr. Prager as the new ECOG senior investigator, and Herbert C. 
Hoover, Jr., MD, will succeed him as principal investigator ofNSABP. Dr. Prager 
will continue as an active member in both groups and will continue to participate 
in their clinical trials program. 
I want to acknowledge David's contribution to the cancer program at Lehigh 
Valley Hospital. The patients and families of Allentown owe him a significant debt 
for his role in establishing the high quality of oncologic practice in this 
_ communitY._~ In addition, through David's ECOG and NSABP leadership, both 
. ''"/ihysidansand patients"haveparticipafed"iiiadvancing the outcomes of cancer 
- ··treatmenHhrough·theirparticipatiorrin-clinictJl-trials. · ·· 
Chuck Hoover and I are looking forward to continuing the tradition of clinical 
investigation started by Dr. Prager. We plan to expand the clinical research 
mission further through our academic collaboration with Penn State University 
Cancer Center at Hershey and our clinical affiliation with the Johns Hopkins 
Oncology Center. 
Gregory R. Harper, MD, PhD 
Director, Morgan Cancer Center 
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Abington Memorial Hospital Joins Penn CARE 
Abington Memorial Hospital has 
joined the- Penn CARE integrated 
health care delivery system, bringing 
the number ofhospitals to 11 
employing 13,000 people, with 
. _combined medical staffs of3,000 
physicians. More than 3.7 million 
residents live in the counties now 
served by PennCARE providers, an 
area measuring 5,400 square mile.s. 
This new addition makes PennCARE 
the largest health care network in 
Pennsylvania from the standpoint of 
beds (2,528), inpatient admissions per 
year (112,000), and emergency 
department visits per year (315,000). 
Abington Memorial Hospital is a 
regional acute care hospital with 508 
licensed beds and a medical staff of 
more than 600 physicians and 3,500 
employees, providing medical care 
and health services to residents in 
Bucks, Montgomery, and Philadelphia 
counties. The hospital has the only 
Level II accredited trauma center in 
Montgomery County, and offers 
highly specialized services in cancer 
care, maternal-child health, and 
cardiac care. Last year, the hospital 
had more than 21,000 inpatient 
admissions and 436,000 outpatient 
visits. 
··-·-·- · ""Ournew"PenneAREl'mtners add-
- -~--tremeBdously~o -th.e-bre8dtb..and.depth -~ 
of medical care available to the people 
of eastern Pennsylvania through a 
single, integrated network," said Elliot 
J. Sussman, MD, Chairman of the 
Board and President ofPennCARE. 
''They share the vision of other local 
health care systems in PennCARE, 
that local health care decision making 
through a provider-led network is the 
best way to care for our communities." 
Other partners in PennCARE include ) 
the following hospitals and 
participating members of their medical 
staffs: Doylestown Hospital; Easton 
Hospital; Gnaden Huetten Memorial 
Hospital in Lehighton; Grand View 
Hospital, Sellersville; Hazleton 
General Hospital; Hazleton-St. Joseph 
Medical Center; Lehigh Valley 
Hospital; Muhlenberg Hospital 
Center; North Penn Hospital, 
Lansdale; and Pocono Medical Center, 
East Stroudsburg. 
The PennCARE network was 
introduced in May 1995 and began 
contracting with managed care 
companies in August 1996. 
The PennCARE network does not 
involve the merger of assets; each 
member remains independent and has 
agreed to participate in mutual ) 
contracting, consistent medical 
management and single data collection 
to measure and improve health 
outcomes of individuals covered under 
its health plans. 
Patient Death Notification 
If a patient dies, it is the attending 
physician's responsibility to notify the 
·iamily. -·lf1here·is another attending 
.. physician .from another faciUty (i.e., 
Allentown State Hospital) who referred 
the patient to Lehigh Valley Hospital, AS 
A COURTESY, the attending physician at 
Lehigh Valley Hospital should contact the 
attending physician at the referring facility 







Sixty percent of all hospitals surveyed 
thus far in 1997 have received a Type 
1 recommendation during the survey. 
-· . -. (A Type l recommendation··recognizes 
a serious deficiency in the hospital's 
processes and affects accreditation 
status.) Your help will prevent us 
from being added to that number. 
Remember: 
• A new order must be written every 
24 hours after a face-to-face 
assessment by the physician 
(physician order sheets are 
available). 
• Documentation supporting the 
continued use of the 
restraint/seclusion must be found 
in the progress notes. 
• The order must contain the 
following: Date/Time, Type of 
Restraint, Purpose for Restraint, 
Criteria for Discontinuation, 
Length of Time for Restraint 
(additional requirements for 
Psychiatry/Behavioral Health 
Patients include RN' s ability to 
reassess for continued use of 
restraint/seclusion). 
• TelephoneN erbal Orders must be 
co-signed within 24 hours. 
. ,J.CAHQ_sllzyeyors will look for 
.::- · -complianoe-with the . above4aring .. 
· their reView of operi-and closed 
medical records and in the interview 
sessions. 
Medica dons 
Our process for controlling sample 
medications will be looked at closely. 
Reminders: 
• All sample medications must enter 
through the pharmacy (the 
specifics needed will be logged in 
according to policy). 
• When medication samples are 
dispensed, all necessary 
information must be documented 
on the sample dispensing log 
sheets (required in case of a recall 
or follow-up). 
Medical Records 
Patient confidentiality must be 
maintained at all times. 
Remember: 
• To follow policy in regards to 
medical record security. 
Outpatient Services 
Lehigh Valley Hospital at Cedar 
Crest & 1-78 provides a designated 
location for outpatient services 
related to diagnostic imaging and 
outpatient laboratory work. The 
services are provided in the 1230 
medical office building in Suite 1 04 
and 102, respectively. In order to 
serve our patients more effectively 
·and ,efficiently, please communicate 
·· this information to your patients to 
assure that they arrive at the right 
location for their testing. 
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Reminders and Notes from Transfusion Service 
Blood Transfusion and 
Hepatitis Notification 
When blood transfusion is implicated 
as a cause of Hepatitis, the 
···Transfusion Service needsto be 
notifiea in order to convey this 
information to the regional blood 
collecting facilities so that the donor 
of the unit is identified as potentially 
infectious and deferred from further 
blood donations. To notify the 
Transfusion Service, please call the 
Blood Bank at 402-8181. 
HCVTesting 
Recently, the American Liver 
Foundation has recommended 
(through advertisements in the press) 
that persons who have received blood 
transfusions prior to May, 1990 be 
tested for HCV. These individuals are 
being identified as high risk for 
developing chronic liver disease. . 
The first generation HCV test was 
approved by FDA in May, 1990, and 
most blood centers had started testing 
the donor blood immediately. 
Cirrrently, a second generation test for 
HCV is available. This has eliminated 
a large number of false positive tests 
seen with the first generation test. To 
. dat~A/AABB o~,.CDC have not 
·issued-any fonnal-guidetines on this .. 
issue~--We are closely monitoring this 
and will immediately relay any 
information that becomes available to 
us. In the meantime, it is 
recommended that if you have any 
such patient in your practice, that you 
give serious consideration to obtaining 
a HCV test on these patients. The test 
is performed on the serum, and can be 
ordered individually or as part of a 
Hepatitis profile. 
The risk of acquiring transfusion 
associated HCV is 1:100,000. The 
risk of acquiring transfusion 
associated HBV is 1 :60,000. 
Maximum Surgical Blood 
Ordering Schedule (MSBOS) 
As you may know, the MSBOS went 
into effect on August 1, 1997. The 
Transfusion Service will make a 
monthly report to the Transfusion 
Committee as to the effectiveness of 
this process. This is a performance 
improvement (PI) indicator to meet 
JCAHO expectations. Since the 
MSBOS was presented at most 
individual division meetings prior to 
finalizing the program, it is hoped that 
everyone will be an active participant 
in this PI. If you have any questions 
or concerns regarding the schedule, 
please e-mail or call Bala B. Carver, 
MD, Director, Transfusion Service, at 
402-8142. 
Price Increase in RhiG 
(RhoGam) 
The companies that manufacture this 
product are anticipating a marked 
increase in the pricing due to a FDA 
mandated purification step to 
eliminate any possible infection 
.potential. The manufacturers deeply 
r~gret this increase, but feel they have 
no choice in the matter but to comply 
with the FPA mandate. The expected 
increase is fourfold over the current 
pncmg. 
Medical Staff Trivia 
According to Medical Staff Services records, 
60 members of the Medical Staff are married 







Just a reminder that all physicians, 
nurse midwives, and nurse 
practitioners who attend deliveries are 
required to be up-to-date on this 
certification. 
·-
For your convenience, Neonatal 
Resuscitation recertification! 
certification will be held during the 
month of September. This will be 
your ONLY opportunity to recertify/ 
certify for 1997 and 1998 -- if you 
expire in 1998, make sure that you 
attend. 
The dates and times are as follow: 
• Friday, September 5, at 7 p.m. 
through Monday, September 8, at 
?a.m. 
• Friday, September 12, at 7 p.m. 
through Monday, September 15, at 
?a.m. 
• Thursday, September 18, at 11 
a.m. through Friday, September 
19, at 3 p.m. 
• Thursday, September 25, at 11 
a.m. through Friday, September 
26,at 3p.m. 
All sessions will be held in the "old" 
ICU area at 17th & Chew. Take the 
blue elevator to the 4th floor and turn 
right. 
If you must perform intubation, 
neonatology may or may not be 
available during the time that you 
recertify/certify. Please call to check 
availability. For more information or 
if you have any questions, please 
contact Wendy Am.ig, Perinatal 
Patient Care Specialist, at 402-3895 or 
beeper 5100-9769. 
Bristol-Myer~ Blood Pressure Study 
Individuals are currently being 
recruited for a Phase IT 14-week drug 
dosing blood pressure study. The 
drug, BMS-186716, is a potent 
metalloprotease inhibitor to be utilized 
as a once-a-day antihypertensive 
agent. This project is being 
supervised by-Nelscm.P ... Kopyt, DO, 
and Gina M. Karess, MD, at 17th·& 
Chew. Th~--Clinical Research·· · 
Specialist is Marianne Y. Benioff, RN, 
BSN. All participants will receive 
free medications, exams and testing. 
Enrollment is open until the end of 
September 1997. The project is to be 
completed by January 1998. Criteria 
for the study protocol are as follows: 
1. Age 18 or older 
2. Male or female (must be surgically 
sterilized or post-menopausal) 
3. Hx of mild to moderate HTN 
(SeDBP 95-11 OmmHg). 
For additional information, contact 
,,Marianne .Benioffat 402-9524. 
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Library News 
OVID Training 
To schedule a one-on-one OVID 
(MEDLINE) training session, call 
Barbara lobst in the Health Sciences 
. Library at Cedar Crest& I-78 at 
402-8408. 
Library Construction - Cedar 
Crest & 1-78 
Construction will begin in the near 
future for the Meyer Cohan Learning 
Resource Center (LRC). The LRC 
(virtual classroom) is designed to be a 
multipurpose, multimedia classroom 
for the delivery of medical education. 
It is anticipated that the construction 
will take about 2 1/2 months. 
New Additions to the Library 
Collection 
The following books were recently 
acquired by the Cedar Crest & 1-78 
Library: 
AJCC Cancer Staging Manual, 5th 
edition 
Author: American Joint Committee 
on Cancer 
Call No. QZ 241 A312 1997 
(Reference Section) 
···-:::.,~·-...:.:·:.:;·"'C1HTelltTherapy in-Eadocrinology· -- · ~­
.: ~ . .. : ~::-.:.: ... and.Metabollsm, 6th ~tipn · ·_=...___ 
Author: C. Wayne Bardin 
Call No. WK. 100 B235c 1997 
Disease Management: A Systems 
Approach to Improving Patient 
Outcomes 
Author: Warren Todd, et al. 
Call No. W 84.7 06111996 
Guide to Clinical Resource 
Management 
Author: Mickey Parsons, et al. 
Call No. W 74 G945 1996 
Publications purchased for the 17th & 
Chew Library include: 
Clinical Gynecologic Oncology, Sth 
edition 
Author: Philip DiSaia, et al. 
Call No. WP 145 D611c 1997 
Clinical Obstetrics and Gynecology 
Volume 40, Number 2- June 1997 
Topic: "Managed Care and the 
Obstetrician/Gynecologist'' 
Guest Editor: Arnold Cohen 
The Fragile Alliance: An 
Orientation to the Psychiatric 
Treatment of the Adolescent, 4th 
edition ) 
Author: John Meeks 
Call No. WS 463 M494f 
Breaking Free of Managed Care: A 
Step-By-Step Guide to Regaining 
Control of Your Practice 
(Behavioral Health) 
Author: Dana Ackley 
Call No. W 80 A182b 1997 
Rheumatology in Primary Care 
Author: Juan Canoso 







Deborah N. Kimmel, MD, Division of 
Physical Medicine/Rehabilitation; 
Alexander D. Rae-Grant, MD, Medical 
Director, Neurodiagnostic Lab; Sharon 
Bartz, Staff Assistant; Kathleen Bodnar, 
RN; Nancy J. Eckert, RN, Clinical 
- ·ResearchSpecialist; and John Graham, 
BS, CSCS, Director, Human Performance 
Center, have become members of the 
Consortium of Multiple Sclerosis 
Centers. The Consortium ofMultiple 
Sclerosis Centers comprises centers from 
all around the world dedicated to 
education, advocacy, and research, and 
new management strategies of 
management of multiple sclerosis. 
Sophia C. Kladias, DMD, Division of 
General Dentistry, received the Academy 
of General Dentistry's prestigious 
Fellowship award during the convocation 
ceremony at the Academy's 45th annual 
meeting held in Chicago, Til., on August 
2. 
Papers, Publications and Presentations 
George A. Arangio, MD, Section of 
Orthopedic Trauma, had two articles 
published iri. recent months --
"Biomechanical Study of Stress in the 
Fifth Metatarsal" in the March, 1997 
issue of Clinical Biomechanics, and 
"Reemployment ofPatients with Surgical 
Salvage of Open, High-Energy Tibial 
Fractures: An Outcome Study" in the 
May, 1997 issue of the Journal of 
Trauma. 
Peter A. Keblish, Jr., MD, Chief, 
Division of Orthopedic Surgery, was an 
invited member of the guest faculty of 
Summer University at the University of 
Edinburgh at Scotland UK in June. The 
Summer University, held under the 
direction of the faculty of the University 
and Mr. Peter Abernathy, is designed to 
treat specialized subjects for the newly 
_ .. -graduated..orthopedic -r.egistrar.s in the UK 
---····1md-other comrtriesin Europe. The -
· UniversitY-is fashioned after the Suniiner 
Institute held in the United States, under 
the direction of the American Academy 
of Orthopaedic Surgeons. 
Dr. Keblish was involved in moderating 
and directing case study groups as well as 
presenting formal lectures and 
demonstrations. He presented several 
topics on subjects including surgical 
approaches, techniques and experience 
with primary and revision total knee 
replacement. 
Dominic P. Lu, DDS, Program Director, 
Dentistry Residency, had excerpts from 
his study, "Clinical Comparison of 
Various Intramuscular Sedation Agents 
and their Reversal Drugs" published in 
Vol. 25, No. 1, 1997 of Pain Control. 
Michael Sheinberg, MD, Division of 
Primary Obstetrics and Gynecology, co-
authored a research paper, "Application 
ofTelethermography in the Evaluation of 
Preterm Premature Rupture of the Fetal 
Membranes," which was published in 
Volume 30, Number 6, November/ 
December 1996, of Biomedical 
Instrumentation & Technology. 
Michael Weinstock, MD, Chairperson, 
. .Department .of Emergency Medicine, will 
· ··provide·the Keynote Address-- Our 
Specialty, Ourselves: Where We Stand--
at the 4th Annual Emergency Medicine/ 
Emergency Medical Services 
Convergence to be held at the Split Rock 
Resort in Lake Harmony from September 
19-21. In addition, Dr. Weinstock will be 
one of the program presenters for New 
Frontiers in Acute Stroke Management, to 
be held on Saturday, September 20, from 
11 a.m. to 1 p.m. 
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Upcomi~g Seminars, Conferences and Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held every 
Tuesday from noon to 1 p.m., in the 
hospital's Auditorium at Cedar Crest 
& 1-78. 
Topics to be discussed in September 
include: 
September 2 - Infectious Disease 
September 9 - Rheumatology 
Who's New 
The Who's New section of Medical 
Staff Progress Notes contains an 
update of new appointments, address 
changes, status changes, etc. Please 
remember to update your directory and 
rolodexes with this information. 
September 16 - Department of· 
Medicine 
September 23 - Geriatrics 
September 30 - Endocrinology 
For more information, please contact 
Becky Sherman in the Department of . 
Medicine at 402-8200. 
As our second class of residents starts, 
the Family Practice Residency will have 
a much more active inpatient teaching 
service which will include adults, 
children, and birthing. 
Medical Staff 
In order to assist hospital staff, a 
coverage schedule of days, nights, and ) 
Change of Practice Affiliation 
Kenneth G. Ryder, Jr., MD 
(no longer with Shepherd Hills Family 
Practice) 
(Opening solo practice September 2) 
4955 Route 873, Suite B 
P.O. Box388 
SchnecksVille, PA 18078-2211 
(610) 799-4100 
~:· FAX:'\61"0)799-410~-
~ · .. --
Change of Address 
Michael L. Zager, MD 
(Lehigh Internal Medicine Associates) 
East Penn Family Practice 
1040 Chestnut Street 
Emmaus, PA 18049-1998 
(610) 967-4830 
FAX: (610) 965-7737 
weekends has been distributed to all 
clinical care units. 
We ask that our charts be identified as 
"FPS" (for Family Practice Service) in 
addition to identification of the 
attending, e.g., "White/FPS". 
For our physician colleagues, we ask 
that you follow hospital guidelines for 
consultation and teaching when 
assisting .in the care of our patients. 
We are looking forward to developing 
productive, educational, and patient-
care relationships with you. 
Brian Stella, MD 





A Service of lEHWVAILEY 
HOSPITAL 
International Cytology Conference 
Hawaii, USA· June 5 to 10, 1997 
The International Academy of Cytology organized, for 
the first time in its history, an international conference 
on Diagnostic Cytology Towards the 21st Century. 
This conference was held on the big island of Hawaii 
from June 5 to 10, 1997. It was entirely different 
from many previous lAC meetings, tutorials, and 
world congresses in cytopathology. · It dealt 
predominantly with selected topics prepared in 
advance and comprising 11 task forces. Their prime 
'
). goal was to lay the foundations for future diagnostic 
cytology practice in the 21st century. The 11 task 
force topics were as follows: 
) 
• Atypical squamous cells of undetermined 
significance (ASCUS) and atypical glandular 
cells of undetermined significance (AGUS) 
criteria. 
• Human papilloma virus (HPV) and cervical 




• Quality assurance and,quality controlisstJes. ::":" ,. _ 
• Computerized screenir19 de~ices. 
• Cost/benefit assessments of automated devices. 
• Cell preparation methods and sample adequacy 
criteria. 
• Colposcopy, endoscopy, cervicography, 
speculoscopy. . 
• Medical/legal implications of automated 
prescreening. 
• Automation in cytology education and proficiency 
testing. 
Each task force was chaired by an individual of most 
prominent experience and contributions to the body 
of diagnostic cytology literature. In addition, there 
were three to four co-chairs who had the function of 
helping the chairman with his obligations. Varying 
numbers of contributors submitted short 
commentaries on particular areas of interest or 
experience within the subject matter of each topic 
forwarding their comments (about three pages single 
spaced) to the Chicago conference office. The 
collated and duplicated contributions were then 
forwarded to the chairs and co-chairs from Chicago. 
It was the job of the chairs and co-chairs to consider 
the submitted material for possible entry into the 
position papers. The chairs, in cooperation with their 
co-chairs, prepared preliminary position papers for 
eventual presentation at the conference, sending a 
hard copy and a floppy disk, to the Chicago 
· conference office for reproduction and insertion into a 
three-ring binder. It was only then that the Chicago 
office prepared the material for insertion into the 
- three-ring binder which contained the final position 
__ papers and all contributions submitted by the task 
·. ··:·for~-members.-1>uring the cooference, which took 
---,_ place betweerfJtlne 6 and·'1u; an·taskiorce 
members and every conference registrant had the 
opportunity to participate in the actual deliberations. 
The questions and/or comments will appear in the 
printed version of the Task Force Proceedings in 
August. Thus, all position papers, including the 
contributions, would be prepared for publication. The 
contributors will have the opportunity to amplify 
and/or modify their manuscripts before materials go 
to press. Acta Cytologica will devote the entire 
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January/February 1998 issue to the achieved 
consensus as well as topics of significant interest to 
gynecologists which will appear in the Journal of 
Reproductive Medicine. · 
There were five conference lectures of outstanding 
interest and important medical/scientific data for the 
benefit of all participants in this international 
conference. On Friday, June 6, the first conference 
lecture submitted by Harubumi·Kato, MD, PhD, FIAC, 
Tokyo, Japan, was on Cytologic Findings in Early 
Central Type Lung Cancer and Their Endoscopic 
Appearances. The same day, a second conference 
lecture was given by Shiro Nozawa, MD, PhD, MIAC, 
Tokyo, Japan, on Novel Enzyme Immunoassay for 
Endometrial Cancer using cytologic specimens. On 
Saturday, June 7, a conference lecture by Yoshio 
Tenjin, MD, PhD, FIAC, and Tadashi Sugishita, MD, 
FIAC, Tokyo, Japan, was on New Approaches to the 
Evolution of Diagnostic Cytology, focusing on the 
correlation between cell morphology and genetic 
changes. On Sunday, June 8, the conference lecture 
by Professor Nils Stormby, MD, PhD, FIAC, of 
Malmo, Sweden, was on Clinical Cytology, a 
Valuable Diagnostic Tool in a Tight Health Economy. 
Finally, the last conference lecture by Mark A. 
Shiffman, MD, MPh, and Diane Solomon, MD, MIAC, 
National Cancer Institute, NIH, Bethesda, Md., was 
on The Comparison of Cervical Cancer 
Methodologies. 
Although each task force was supposed to deal 
primarily with its specific subject matter, it became 
quite evident during the deliberations and 
discussions that many of the participants had 
justifiably made quite numerous incursions into 
neighboring fields of other specific subject matters. 
The impression gained was that all task forces were 
united by a common'thread·of-interdisciplinaty · . 
structural relationships. Throughout-the-entire ·· . . . 
conference, this outstanding feature was particularly 
noticeable during the presentation of the various 
position papers and the discussions that emanated 
thereof. 
Finally, a word on the choice of the venue of this 
important international conference. The site of 
Hawaii was not selected, in my opinion, for this work 
intensive and trend setting conference only to 
facilitate access from Pacific rim countries. It truly 
projected an image of an intensely awe inspiring 
venue by virtue of its unique attractive 
geologic/volcanic makeup compelling all to realize 
that one could not escape feeling close to the 
.creation of planet Earth. 
Harry Z. Suprun, MD, FIAC 
Department of Pathology 
Division of Cytopathology 
Lehigh Valley Pathology Associates 
Lehigh Valley Hospital 
David G. Beckwith, PhD, Vice President, 
Network Laboratory Services, and Clinical 
Director, Health Network Laboratories, was 
recently the keynote speaker at the St. Louis 
Chapter of the Clinical Laboratory 
Management Association and participated in 
two Edu-trak sessions on laboratory 
management and laboratory automation at the 
annual meeting of the American Association of 








DRUG INFORMATION BULLETIN 
Pharmacy Department- July, 1997 Editors: Maria Barr, Pharm.D.,BCPS, Howard Cook, R.Ph., BCNSP, FASHP . 
Barbara Leri, Pharm.D., Rebecca Hockman, Pharm.D. ' 
The following ~ormation was distributed.to the housestaff in July, 1997. As a means of communication with the 
Attending PhySicians, the Drug Information:Bulletin is being reprinted. PI~ _review the information and contact 
the pharmacy .if any questions arise. 
PHARMACY WELCOME TO THE 
NEW HOUSE STAFF 
Our Phannacy staff would like to extend a 
sincere welcome to the new house staff. Our 
department provides a comprehensive service 
to patients, physicians, and staff as an integral 
part of the patient care, teaching, and research 
programs. This newsletter is a part of that 
service, and our goal is to keep you informed 
of recent activities of the Therapeutics 
Committee and the Food and Drug 
Administration. 
Each year a few issues commonly require 
clarification by the Phannacy Department. 
Please take note of the following: 
PHARMACY AT THE POINT OF 
SERVICE! 
Pharmacists are no longer confmed to the 
basement! Unit Based Pharmacy Services 
have been instituted house wide since the 
initiation of Patient Centered Care. Every 
weekday from 0730-1600 and until 2200 on 
floors 4-7, pharmacists are unit based to 
perform order entry for his/her assigned area 
as well as various clinical functions. 
Clinical 'functions of our ~pharmacy staff 
include activities such as proyidiiJ.g drug 
information, drug dosage adjustments, 
pharmacokinetics, alternative therapy options, 
IV-PO conversions, and patient teaching. The 
Unit Based Pharmacist is an indispensable 
resource to assist you throughout your day. 
Cellular phone nwnbers and beeper nwnbers 
are listed in the newsletter for your 
information. Pharmacist phone/pager numbers 
can also be found posted on patient care areas. 
..,.,.. .... 
Do not hesitate to contact a unit based 
pharmacist or the main pharmacy with 
questions at any time. 
The Pharmacy Department houses a wide 
variety of journals and texts to answer drug 
related questions. Also, the Micromedex 
system, a computerized CD-ROM based 
clinical information system containing features 
such as Drugdex, Indentidex, Poisondex, and 
Emergendex is available on the hospital 
network to all pharmacists and physicians. 
THE HOSPITAL FORMULARY 
The Lehigh Valley Hospital Formulary is 
developed under the auspices of the 
Therapeutics Committee which acts as an 
advisory group to the Medical Staff concerning 
drugs and their usage. The Hospital Formulary 
serves as a teaching aid, as well as a guide and 
standard for prescribing drugs. The formulary 
is available in a binder format on all nursing 
units. Each version is arranged in six parts: 
Part I- Formulary Information and Procedures 
Part II - Fomiulary Drugs by Category · 
Part. ill - Formulary Generic Drug List 
Part IV- Section unused at this time 
Part V - Appendices 
Part VI - Parenteral Nutrition Order 
- ____ _ Guidelmes .,- -· 
Part VID7 ""<·Physician's Assistant-Formulary 
Please note some of the useful tables and 
charts that are available in the appendices: 
- Medication Administration Times 
- Adverse Reaction Reporting System and 
Reporting Form 
:.. Antacid, Vitamin Comparison Chart 
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- Narcotic Analgesics Comparison/ 
Conversion 
- Standard Diluent, Volume and Infusion 
Rate Schedule 
- Medication Stop Order Policy 
- Therapeutic Equivalent Substitution List 
DEA NUMBERS . 
Temporary DBA numbers may be assigned to 
the new residents upon request of the 
residency directors. The Pharmacy assigns 
each resident's temporary DBA number, but 
each specific department (i.e. Medicine, 
Surgery, Family Practice, OB/GYN, ED, and 
Dentistry) must relay this information to the 
resident. Please note the temporary D EA 
number for all residents is the site's Pharmacy 
DBA number plus a unique three digit suffix. 
Each resident will have two separate DBA 
numbers one for use at Cedar Crest & 1-78 
and one for use at 17th & Chew. 
PRESCRIPTIONS 
Residents may obtain prescriptions from 
Health Spectrum Pharmacy at cost plus a 
dispensing fee for him/herself and dependent 
relatives. The prescription will need to be paid 
for at time the medication received. 
Prescriptions are not filled by the inpatient 
pharmacy department. 
STANDARD/PREMIXED IVS 
Drugs with standardized diluent, volume and 
infusion rate (when applicable) are listed in 
Formulary Appendix X. When ordering any of 
these drugs, please write only the dosage, 
route and frequency on the order sheet. 
Include diluent and/or volume only if it is 
medically Il!=~ss;u:y ancL~Y\te it .as such on the __ .. 
physician's order. For example, writing 
Cefazolin lOrn 1V -Q8H-issttfficient -to order · ---~ 
this dose. The cefazolin will be dispensed in a 
syringe with an appropriate volume of diluent 
(lOml of sterile water for injection) and the 
rate of infusion will be dependent on volume 
in the syringe. The diluent needs to be 
indicated only if mandated by patient's clinical 
condition. (i.e. patient is fluid restricted). 
A list of the standardized or premixed 
continuous infusions can be found in Appendix 
XIV. Some of these include Heparin 25,000 
units/250ml, Insulin 50 units/lOOml, Morphine 




Orthopedic (hip and 







warfarin and/or low 
molecular weight 
heparin (*only for high 
risk patients defined by 
VTE protocol) until 









and current thombotic 
regimens (Poor 
literature support for 
use of LMWH post 
intervention). 
-*'Note-that presently, low molecular weight 
heparin (formulary: enoxoparin (Lovenox) 
30mg SQ Q12H) is restricted to high risk 
trauma patients. In the rare instance that a 
patient must receive enoxaparin due to 
difficulty in blood draws to monitor INR's for 
warfarin adjustment, it must be clearly noted 








A preprinted weight-based heparin order sheet 
is available for use for all patients requiring 
continuous infusions of heparin. The heparin 
dose should be based on total body weight for 
both the bolus and maintenance dose. There 
are scales for the aPTT on the order sheet to 
address dosing .adjustments ofheparin. A -_ 
pocket guide for weight-based heparin is 
available for review for use of parenteral 
heparin. 
TPA 
There are specific guidelines used in dosing 
TPA. Preprinted order sets can be found in the 
Emergency Departments and Coronary Care 
Units for its use for Acute MI. The order sets 
include all the available thrombolytic agents 
with strategies for Acute MI. Please note the 
weight dosing parameters for patients weighing 
less than 65Kg found in the guidelines. Due to 
the urgency required in ordering TP A, it 
would be helpful for the physician to call the 
pharmacy IV room (ext. 8879) directly or have 
the order brought to pharmacy to expedite the 
compounding and delivery of this medication 
for the patient. A written order indicating the 
patient's weight and desired dose must be 
received prior to dispensing. The pharmacy 
department will deliver the thrombolytic agent 
to patient care areas. 
TPA may also be used for acute ischemic 
stroke (initiated 0-3 hours after symptom 
onset) and in acute pulmonary embolism. The 
protocols follow. 
Acute ischemic stroke: 
0.9mg/Kg (total dose_.=:;_ 90mg) 
--io%- dosew bofUS- - - :_ . 
Remaining 90% I111l""''Yer-6e-minutesq 
Acute pulmonary embolism: 
1 OOmg give over 2 hours 
(not weight dosed) 
ELECTROLYTE DOSING 
KCL 
The Therapeutics Committee (5/93) approved 
the following rate and concentration 
parameters for potassium administration. 
1. Peripheral I:.ine for All Units (non-
monitored and monitored patients); 
IY·Infusion: 20mEqlhr (2.0mEq/1 OOml with 
80mEqlbag .limit) 
IV Bolus: 20mEqlhr (20mEq/100ml with 
20mEqlbag limit) 
2. Central Line Limits- Non-Monitored 
Patients: 
IV Infusion: 20mEqlhr (40mEq/100ml with 
80mEqlbag limit) 
IV Bolus: 20mEqlhr (lmEq/1ml with 
40mEqlbag limit) 
3. Central Line Limits - Monitored 
Patients: 
IV Infusion: 40mEqlhr (1mEq/100ml with 
80mEqlbag limit) 
4. Maximum Daily Doses: 300mEq per 
24 hour period 
* To reduce the risk of phlebitis, it is · 
recommended that sterile water be utilized as 
the diluent, especially when concentrations 
exceed 1 OmEq/lOOml 
* All solutions with a concentration greater 
than 1mEq/10nil must be administered via an 
electronic rate controlling device regardless of 
{}el~ery ~ite. - -
~----- .. ,. _____ _ 
WHEN TO USE SUSTAINED-RELEASE 
KCL 
The sustained-release (SR) or time-release(TR) 
form is preferable for patients who need KCl 
supplements chronically. Immediate-release 
products, such as the KCl elixir and the 
intravenous form, are indicated when 
hypokalemic patients need immediate 
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potassium replacement. Physicians, therefore, 
should request KCl elixir to be given for an 
oral stat or now order. The best way to order 
any medications is to write the generic name, 
suffix with SR only if sustained-release form is 
desired. The following examples are 
illustrations Qf the types of orders desirable 
when requesting an .oral KCl dose: ----
Physician Order/ Pharmacy Dispenses 
(Per Dose) 
KC140mEq po stat/now- KC140mEq elixir 
KCl SR 20mEq po -K-Dur 20mEq tab 
KCl 20mEq via NGT -K-Dur 20mEq* 
* Aqueous K-Dur suspension maintains SR 
property (Not for STAT/NOW USE), 
Recommended that 1 tablet be dissolved (NOT 






rate..$.. 5ml/min (500mg/min; 2.5mEq/min) 
eguivalents: One 10%ml/amp = 1gm Calcium 
gluconate = 4.6mEq Ca.= 93mg Ca 
Calcium Chloride 
dose: 0.5-1gm (5-10ml); 
rate..$.. 1ml/min (100mg/min; 1.5mEq/min) 
eguivalents: One 10% m1 syringe = 1gm 
CaC12 = 13.6mEq Ca = 272mg Ca 
Magnesium 
Standard IV bolus: 
for serum Mg 1.6-2.0mg/dl: 
8mEq .Mag··Sulfl5emt-D5W. -- -
( = 1gmfMag Su_lf,giv_en over lfz hr · 
for serum mMg < 1.6mg/dl: 
16mEq Mag Sulf/100ml DSW 
( =2gm) Mag Sulf given over 1 hr 
Oral equivalents: 
Magnesium Chloride (slow-mag) time released 
1 tablet = 535mg MgC12 
= 64mg Mg 
= 5.4 mEq Mg+ + 
Magnesium Gluconate 
_ 1 tablet = SQOm.g Mg glucenate 
= 27 mg Mg. 
= 2.25 mEq Mg+ + 
5mlliquid = 1 OOOmg Mg gluconate 
= 54mgMg 
= 4.5 mEq Mg++ 
Phosphorus 
Potassium Phosphate: lml contains 
4.4 mEq K+ 
3 mM phosphate 
Sodium Phosphate: 1ml contains 
4 mEq Na+ 
3 mM phosphate 
IV Infusion: usual dose 15-30 mM 
phosphate/liter over 6-8 hours 
for serum P 1.0-2.0mg/dl: 
15 mM ( < 7mM/hr) 
for serum P< l.Omg/dl: 
30mM 
*The highest dose reported is 0.125mM/Kglhr 
(rate..$.. 7 mMihr) for 4 hours. The dose is 
recommended only for patients with normal 
renal function noted to have initial serum 
phosphorus concentration < 0.5mg/dl. 
Recheck the serum phosphorus concentration 
at the end of the infusion. 
PARENTERAL ANTIBIOTIC 
ORDER SHEETS·(PAOSJ 
Lehigh V-aHey- Hospital utilizes~ separate and 
unique physicians order sheet for parenteral 
antibiotics. This order sheet allows the 
physician to choose preferred formulary 








(assuming normal renal function) . .There is 
also space available to order additional tests 
such as antibiotic levels or cultures. These 
sheets should be used for all parenteral _ 
antibiotics, including pre-op doses. A Pediatric 
P AOS is also available on units with pediatric 
patients. 
Please complete the patient allergy and 
reaction section at the top of the sheet. 
If an antibiotic does not appear preprinted on 
the order sheet, it may be written on the 
bottom of the PAOS. This section is available 
for reserVed antibiotics which need special 
monitoring for drug utilization processing. The 
order sheet should be completely filled out 
with suspected pathogen and site (if empiric 
therapy) as well as special instructions, if 
needed. 
There are suggested usage guidelines on the 
back of PAOS for general pathogenic coverage 
for antibiotics. Refer to these guidelines for 
empiric therapy, if cultures and sensitivities 
are not available. Please attempt to tailor or 
narrow empiric antibiotic therapy once culture 
· and sensitivity results return. Lehigh Valley 
Hospital's antibiogram, updated annually, is 
found in the parenteral antibiotics section of 





250mg TID ($4.74/day) 
(amox/clavulanate) 
500mg TID ($7.08/day) 
ONCE DAILY AMINOGLYCOSIDE 
DOSING 
Patients prescribed ge~tamicin or tobramycin 
should be considered for one~ daily dosing 
unless excluded by the criteria stated below. 
1. Patient neutropenic (ANC < 1000) 








Patient has cystic fibrosis, cirrhosis, 
ascites, or myasthenia gravis 
Pregnant or nursing mothers 
Patients on dialysis or ARF patients 
Aminoglycoside used for synergy for 
staph or enterococcal infection 




b) one kidney 
c) concomitant nephrotoxic drugs 
Detennination of Dose 
a) Calculate CrCI 
b) Detennine dosing weight 
1) Use total body weight (TBW) 
if not obese ( > 20% over 
mw) 
IV-> PO ANTIBIOTIC 
CONVERSIONS 
2) For obese patients take 40% of 
excess weight add to mw 
The Ph~cy Department strongly encourages 
conversion to oral antibiotic therapy as soon as 
clinical conditions pennit. Listed below are 
some common conversions. 
·-- --- . _,_,~~- --,-.,-:-'"-'-::-.;.._ Pb --
c) Dose based on weight + CrCl 
1) ~ 50ml/min · 5mg/Kg/Q24H 
2) 30-49ml/min 5mg/Kg/Q36H 
3) 20-29ml/min 5mg/Kg/Q48H 
4) < 20ml/min 2mg/Kg x1 
Monitor ____ . _ 




500mgQ12H ($5.60/day)·--- - ""' - **b) '"'Obtam-ro\NDOMlevel 6:;;8 "hours 










*Please note: Once daily dosing does NOT 
require traditional peak.and trough levels. 
c) If le~el < 1.0 mg/dl continue therapy, 
obtam level q 5 days. If level 
> 1.0 mg/dl and < 3, increase 
interval by 12 hours. 
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d) Monitor fluid status, cardiac function, 
cultures and sensitivities. 
HELP CONTROL RESISTANT 
ENTEROCOCCUS 
Prescribers are urged to consider the following 
guidelines for all use of vancomycin to 
decrease the possibility ef emergence of 
vancomycin-resistant S. aureus and/ or -s. 
epidermidis. 
CDC guidelines for Vancomycin use: 
1. Treatment of documented or 
suspected** serious infections with a 
resistant gram positive organism (i.e. 
methicillin resistant Staph aureus-
MRSA, or methicillin resistant Staph 
epidermidis-MRSE). 
2. Treatment of a staphlstrep or other 
gram positive infection in patients with 
serious allergy to penicillin or 
cephalosporin (described as hives 
and/or respiratory distress and/or 
collapse within minutes of a dosage 
of a penicillin or cephalosporin): 
OR, if history of the reaction is 
unobtainable. 
3. PO vancomycin for antibiotic-
associated enterocolitis (due to 
c.difficile colitis) which has failed to 
respond to metronidazole OR is severe 
and potentially life threatenfug. 
4. 
5. 
Use as surgical prophylaxis in patients 
with a serious allergy to penicillin .QI 
cephalosporin (described as hives 
and/or respiratory distress and/or 
collapse wi!hin minutes of a dosage of 
Ji~enicillln ·ar ceph31osporin): OR. if-· 
·history of the-reactiorr is unobtainable. · 
Endocarditis prophylaxis as outlined by 
the American Heart Association for 
penicillin or cephalosporin allergic 
patients. 
NON-FORMULARY DRUGS 
If an order is written for a non-formulary · 
drug, the pharmacy will provide an alternative 
via an automatic substitution list. If a 
substitution is not available the physician will 
be contacted with a recommendation of a 
formulary equivalent or alternative, if possible. 
If no equivalent is available and the medication 
is medically necessary, it will be obtained and 
dispensed as soon as it is available. The 
acquisition Qf the non-formulary item may be 
delayed ·by > 24 hours since the medication 
will need to be ordered from an outside 
pharmacy or wholesaler. If a non-formulary 
drug is brought by the patient from home, the 
pharmacy will dispense the patient's supply of 
the medication to the nursing unit upon receipt 
of a complete physician's order stating, 
"patient may use own medication. " The 
complete name of the non-formulary 
medication, strength, route and frequency must 
be indicated. The pharmacy will not dispense 




Lehigh Valley Hospital has a separate 
parenteral nutrition order sheet which includes 
complete ingredient listings for the available 
standard total parenteral nutrition (TPN) and 
standard peripheral parenteral nutrition (PPN) 
solutions, available in 1 and 2 liter bags. 
·These standard solutions can be ordered at any 
time. Customized solutions can be ordered as 
well, if required. All parenteral nutrition is 
prepared for a 24 hour period of time. 
All parenteral nutrition orders MUST be 
received in the main pharmacy by 1500, to 
allow for adequate preparation time for the 
solutions to be hung at 2100. Late orders will 
. _NOT be honored after fSOO. These late orders 
wiil-be·'COOSidered ·as -parenteral nutrition 
orders for the following day. The ordering 
physician will be notified by a pharmacist if 
this delay will occur. 
All new parenteral nutrition orders and any 
changes to an already existing parenteral 
nutrition order require a completely rewritten 







rewritten order is required every 7 days to 
assure that a current active order is in the 
patient's chart at all times, even if the chart is 
broken down. Parenteral nutrition solution 
orders are valid for a 48 hour period of time. 
Following 48 hours, the physician may reorder 
the same solution on a regular blue physicians 
order sheet by ~riting "SAME TPN", 
"RENEW TPN ... ·or . .a similar .statement if no· 
changes to the parenteral solution are required. 
If the required 48 hour renewal (as above) or a 
completely rewritten parenteral nutrition order 
is not received by 1500, Dextrose 10% will be 
hung in its place. 
INJECTABLE MULTIVITAMIN 
SHORTAGE 
There is currently a national shortage of adult 
parenteral multivitamin formulations, created 
by the discontinuation of one manufacturer's 
product and the exhaustion of the current 
equivalent product, Astra's MVI-12. 
Currently, L VH has adopted the following 
guidelines, based on suggested treatment 
options provided by the American Society of 




Use oral multivitamin supplementation 
whenever possible. Oral liquid 
formulations are available for those 
patients with feeding tubes. 
Preferential use of parenteral 
multivitamins for all parenteral 
nutrition patients. This group will 
receive multivitamin infusion on 
Tuesday, Thursday, Saturday and 
Sunday while supply lasts, or until the 
shortage subsides. 
For all otl,l~r parenteral multivitamin 
.~requestS (and wh.eii~current parenteral 
nutrition ·muitivitamin·stores ·are 
exhausted), the pharmacy has been 
approved by the Therapeutics 
Committee to automatically substitute 
the following: 
Folic Acid 1mg injection 
Cyanocobalamin 100mcg 
injection 
Thiamine 100mg injection 
This policy will continue until the current 
shortage has ended. It should be noted that 
injectable ascorbic acid is also available for 
use, as indicated. 
ALBUMIN SHORTAGE 
Currently, there is an indefinite shortage of 
.5% .and 25% .albumin. · The most common 
reason for use of 5% albumin· is to increase BP 
or urine output postoperatively once the patient 
has been given as adequate fluid challenge 
with a crystalloid such as NSS or lactated 
ringers. After the patient has received usually 
a maximum of 2 L of crystalloid the physician 
may tum to a colloid for effect, since colloids 
remain in intravascular space and decrease risk 
of fluid overload leading to peripheral and 
pulmonary edema. 
25% albumin is used to maintain or increase 
oncotic pressure when a patient's serum 
albumin is < 2gm/dl, with large weepy 
wounds, or to maintain cerebral perfusion 
pressure in patients with subarachnoid 
hemorrhage and pancreatitis. 
Hetastarch 6% 500ml should be recommended 
as a alternative for 5% albumin 250 or 500ml 
in the following situations: 
. 1. Platelet count is > 50k, since there is 
a caution with the use of Hetastarch 
with thrombocytopenia. 
2. Normal renal failure. If patient still 
has any renal function, hetastarch can 
be used. 
3. No severe bleeding disorders, such as 
ITP, etc. 
4. <Nora>CNS (head injury_patient). 
Hetastar.ch can cause ..an increase in 
ICP's. 
Usual adult dose of Hetastarch (500ml 
Hetastarch = 500ml 5% Albumin): 30-60gm 
(500-1000ml)) Hetastarch over 1-2 hours. 
Usual daily dose = 20mg/kg/day to a 
maximum of 1500ml/day. Slight lab 
jlbnormalities have been seen with platelet 
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function, PT and PTT, not associated with an 
increase in clinical bleeding, with volumes of 
> 1500ml/day. 
In severe renal impairment (est. CrCl < 
10ml/min), use the same initial dose but 
subsequent doses should be reduced by 25-
50%. 
Hetastarch Precautions and Contraindications 
include: 
1. Caution in patients with 
thrombocytopenia. 
2. Caution with patients with a history of 
liver disease with underlying elevated 
bilirubin. 
3. Contraindication for the management 
of cerebral vasospasm associated with 
subarachnoid hemorrhage. 
4. Contraindication in patients with 
severe bleeding disorders, renal failure 
with oliguria or anuria. 
Hetastarch Adverse Effects include: 
1. Increased SED rate. 
2. May interfere with platelet function 
and cause transient prolongation of PT, 
PTT and clotting times. 
3. May slightly decrease platelet/ 
hemoglobin concentrations due to 
dilutions. 
4. May increase serum amylase but is not 
associated with pancreatitis. 
For your information, the hospital costs for 
colloids are as follows: 
Albumin 5% 500ml 
Albumin 5% 250ml 
Albumin"25% -lOOmt. 
Albumitl25% 50ml."'_ 






Please limit your prescribing of Albumin 5% 
whenever possible. ·If patients truly necessitate 
Albumin 5% administration, please indicate 
the reason for use on the order to avoid having 
the pharmacist calling the prescriber. If 
possible, attempt to use lower volumes, such 
as 250ml vs 500ml Albumin for first line and 
monitor effects. The patient may only require 
250ml to achieve the desired outcome and this 
would help preserve our presently low stock. 
A concerted effort by all staff will assist the 
hospital in reserving our present supply for our 
critically ill patients who truly need Albumin 
therapy; 
ANTINEOPLASTIC ORDER SHEET 
An order sheet addressing chemotherapy, fluid 
replacement, and pre and post antiemetic 
therapies is available. The sheet includes 
details regarding the patient's necessary 
demographics, laboratory vascular access, and 
investigational protocol information. The 
order sheets are available on 6C, the oncology 
unit. 
IV DILTIAZEM CRITERIA 
FOR USE 
IV Diltiazem was added to the Lehigh Valley 
Hospital Formulary for use in SVT as a 
second-line agent to IV Verapamil. 
IV Diltiazem intermittent boluses and/or 
continuous infusion may be administered after 
meeting at least one of the following criteria: 
1. Failure of I. V. verapamil. 
Failure defined as inadequate HR control after 
a total cumulative IVP verapamil dose of 20mg 
followed by a continuous infusion of verapamil 
1 Omg/br x 1 hour. 
2. And/or Intolerance to a Smg I. V. 
verapamil dose defined as: 
..a. A decrease _in systolic blood 
pressure .. of 10mmHg from 
baseline or-<·90mmHg and 
symptomatic. OR 
b. New onset or worsening CHF 
signs and symptoms. 
c. Documented allergy to 
Verapamil Hcl. 
3. Baseline symptomatic hypotension < 









EF S. 35% and/or PCWP.L_ 
20mrnHg. 
I. V. Diltiazeni will not be used as a 
p.o.substitute in NPO patients. 
• ORDERS MUST STATE REASON FOR 
USE ON THE .PHYSICIAN'S ORDER ... 
SHEET BEFORE THE DRUG CAN .BE 
DISPENSED. 
IF A REASON IS NOT GIVEN, THE 
PHYSICIAN WILL BE CALLED TO 
CLARIFY THE ORDER ACCORDING TO 
THE THERAPEUTICS COMMITTEE 
APPROVED CRITERIA. 
Usual Verapamil dosing: 5-lOmg N bolus 
over at least 2 minutes followed by a 
continuous infusion of 5mg/hr. Dose titration 
to control ventricular rate below 100 beats per 
minute should be done q15-30 minutes at 2.5-
5mg increments. 
ALTERNATIVES TO SUBLINGUAL 
NIFEDIPINE 
Based on recent literature addressing the risks 
of the sublingual "bite and chew" route of 
immediate release nifedipine for acute . 
hypertension, the Therapeutics Committee 
developed the following adult hypertension 
algorithm. (see attaclunent) 
ADVERSE DRUG REACTION (ADR) 
REPORTING 
The standards for the Medical Staff an 
Pharmaceutical Services established by the 
Joint Commission for the Accreditation of 
Healthcare Organizations . (J~O) encourages .. 
hospitals to report -adverse reactions io all food 
and drugs adininisieroo to patients. -rn- an event . '·""". 
of an adverse drug reaction, either suspected 
or documented, an ADR form should be 
completed. A copy of the ADR form can be 
found in the formulary in Section 5, Appendix 
n. The ADR forms are available on all nursing 
units for your use. Please complete and return 
forms to the Pharmacy Department. The ADR 
information can assist the staff in identifying 
trends or patterns of ADR's that require 
further investigation, provide information 
necessary for making formulary 
decisions and recommend new drug 
administration guidelines and find topics for 
drug use review. 
'I:hrough combined effqrts of our house staff 
and hospital personnel the ADR reporting 
system can help to improve overall patient 
care. 
DRUG REPRESENTATIVE POLICY 
Lehigh Valley Hospital has recently 
strengthened its policy regarding 
pharmaceutical company representatives. 
Representatives may meet with physicians, 
nurses, pharmacists, etc. by appointment only. 
Representatives are not permitted to interrupt 
staff members in the halls, on nursing units, in 
the cafeteria, etc. All visits require a 
previously scheduled appointment. The policy 
has been implemented in an attempt to 
maintain better control of formulary items as 
well to contain rising costs of medications. 
Your cooperation with the hospital policy is 
appreciated. Please refer to your individual 
departments for more information. 
PHYSICIAN ORDER SHEET 
CHANGE 
As of July 1, 1997 it will be necessary for 
physicians to specify " "brand necessary" 
in order for a brand drug to be dispensed. 
This is a change from LVH's previous policy 
which authorized brand drug dispensing when 
the drug was simply underlined on the order 
sheet which led to confusion. 
-.Howev.er.,..the.old order .sheets which read, 
"authorization is hereby given to -dispense the 
generic or chemical equivalent unless 
specifically underlined by the physician" will 
remain in circulation until the supply is 
exhausted. New forms will read, 
"authorization is hereby given to dispense the 
generic or chemical equivalent unless specified 
as brand necessarv by the physician. 
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GENERAL AND CUNICAL PHARMACY SERVICE 
Location Service Phone# Beeper# Hours 
) 
Cedar Crest & 1-78 IV Room 8879 24 hrs 
Main Phannacy 8886 24 hrs 
Clinical Phannacy Office 8884 
Unit Based Pharmacy Services 
MICU/SICU/STU UBP 0281 M-F: 7:30am-10:00pm 
ACU/PCU/3C/BU UBP 0258 M-F: 7:30am-4:00pm 
OHU/TOHU -· UBP _98.89 _M-:f: 7:30am-4:00pm 
4A/4B/4C UBP 0246 M-F: 7:30am-4:00pm 
ITU/5B/5C UBP 0273 M-F: 7:30am-10:00pm 
6A/6B/6C UBP 0229 M- F: 7:30am-10:00pm 
7AI7Bnc UBP 0213 M-F: 7:30am-10:00pm 
17th & Chew Pharmacy 
Main Pharmacy 2250 M-F :7:00am-10:00pm 
NICU 2342 
4S Hospice 2331 
4TMBU 7725 
Adl. Psych 2766 
6N 2788 
6S 2347 
IV Room 2744 
TSU (UB) 3300 4738 
Multi-Purpose Area JDMCC Outpatient Chemo 0667 1164 M-F: 7:30am-4:00pm 
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